Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Scientists and organizations are attempting to preserve data by saving it to Substack accounts and personal websites. They're also trying to figure out a new system to share health data, The Hill said ...

Rhapsody’s Chief Product Officer Jitin Asnaani discusses how to connect the dots between disparate patient records from multiple specialist departments to create a clear picture of patient needs.

State-of-the-art transactional repository (rTH): the fully GS1-compliant central hub will securely manage all supply chain ...

Amid a shakeup in U.S. science, researchers are expressing alarm over the integrity of key genetic databases overseen by the ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Standardising analytical data is the key to unlocking AI-driven innovation in chemical and pharmaceutical research. Richard Lee, Director, Core Technology and Capabilities at ACD/Labs explores how ...

On January 22, 2025, the New York State Assembly and Senate rapidly passed the wide-ranging New York Health Information Privacy Act (“NY HIPA”).

AGN Neuro is also pleased to announce that as part of being appointed the CRO, Validcare has agreed to invest US $170K in exchange for equity issued by AGN Neuro. The investment in AGN Neuro will be ...

A 2024 survey of eCOA professionals at sponsor organizations revealed that 50% of respondents identified eCOA Data Change ...